{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:17:14Z","timestamp":1783117034676,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["25ZXWZSY00070"],"award-info":[{"award-number":["25ZXWZSY00070"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jacl.2026.04.020","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T14:46:50Z","timestamp":1777214810000},"page":"1144-1155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The causal association between lipid-lowering drug targets and albuminuria risk: A drug-target Mendelian randomization study"],"prefix":"10.1016","volume":"20","author":[{"given":"Daihui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jacl.2026.04.020_bib1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41581-023-00745-6","article-title":"Inequities in kidney health and kidney care","volume":"19","author":"Vanholder","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.jacl.2026.04.020_bib2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1053\/j.ajkd.2016.01.016","article-title":"Effect of statins on kidney disease outcomes: a systematic review and meta-analysis","volume":"67","author":"Su","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"13","key":"10.1016\/j.jacl.2026.04.020_bib3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/eurheartj\/ehac683","article-title":"Prevention of cardiorenal damage: importance of albuminuria","volume":"44","author":"Ruilope","year":"2023","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jacl.2026.04.020_bib4","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1111\/j.1532-5415.2010.03158.x","article-title":"Albumin:creatinine ratio predicts mortality after stroke: analysis of the Third National Health and Nutrition Examination Survey","volume":"58","author":"Strain","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.jacl.2026.04.020_bib5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2014","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.jacl.2026.04.020_bib6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.ajkd.2015.06.028","article-title":"Cholesterol metabolism in CKD","volume":"66","author":"Reiss","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.jacl.2026.04.020_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S2213-8587(14)70246-3","article-title":"Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial","volume":"3","author":"de Zeeuw","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"21","key":"10.1016\/j.jacl.2026.04.020_bib8","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1503\/cmaj.230093","article-title":"Statin initiation and risk of incident kidney disease in patients with diabetes","volume":"195","author":"Zhou","year":"2023","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.jacl.2026.04.020_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.kint.2017.04.019","article-title":"Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference","volume":"92","author":"Baigent","year":"2017","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.jacl.2026.04.020_bib10","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/ije\/dyx207","article-title":"Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities","volume":"46","author":"Walker","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.jacl.2026.04.020_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12920-024-02020-4","article-title":"Lipid-lowering drugs and risk of rapid renal function decline: a mendelian randomization study","volume":"17","author":"Zhao","year":"2024","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jacl.2026.04.020_bib12","article-title":"Genetic association analysis of lipid-lowering drug target genes in chronic kidney disease","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol"},{"issue":"16","key":"10.1016\/j.jacl.2026.04.020_bib13","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacl.2026.04.020_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacl.2026.04.020_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1681\/ASN.2020050679","article-title":"Conventional and genetic evidence on the association between adiposity and CKD","volume":"32","author":"Zhu","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jacl.2026.04.020_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.23876\/j.krcp.20.186","article-title":"Causal effect of alcohol use on the risk of end-stage kidney disease and related comorbidities: a Mendelian randomization study","volume":"40","author":"Park","year":"2021","journal-title":"Kidney Res Clin Pract"},{"issue":"4","key":"10.1016\/j.jacl.2026.04.020_bib17","first-page":"900","article-title":"The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis","volume":"18","author":"Mazidi","year":"2022","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jacl.2026.04.020_bib18","article-title":"Causal association between tea consumption and kidney function: a Mendelian randomization study","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.jacl.2026.04.020_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2319712","article-title":"Recent advances in the application of Mendelian randomization to chronic kidney disease","volume":"46","author":"Wen","year":"2024","journal-title":"Ren Fail"},{"issue":"3","key":"10.1016\/j.jacl.2026.04.020_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/nu14030509","article-title":"Genetically predicted circulating copper and risk of chronic kidney disease: a Mendelian Randomization study","volume":"14","author":"Ahmad","year":"2022","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.jacl.2026.04.020_bib21","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00198-019-05118-z","article-title":"Health effects associated with serum calcium concentrations: evidence from MR-PheWAS analysis in UK Biobank","volume":"30","author":"Zhou","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jacl.2026.04.020_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2022.03.004","article-title":"Disentangling the association between kidney function and atrial fibrillation: a bidirectional Mendelian randomization study","volume":"355","author":"Geurts","year":"2022","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.jacl.2026.04.020_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/clinchem\/hvab249","article-title":"Obesity and kidney function: a two-sample Mendelian randomization study","volume":"68","author":"Kjaergaard","year":"2022","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.jacl.2026.04.020_bib24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"issue":"5","key":"10.1016\/j.jacl.2026.04.020_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.jacl.2026.04.020_bib26","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/genes13091541","article-title":"TwoStepCisMR: a novel method and R package for attenuating bias in cis-Mendelian randomization analyses","volume":"13","author":"Woolf","year":"2022","journal-title":"Genes"},{"issue":"7","key":"10.1016\/j.jacl.2026.04.020_bib27","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1212\/WNL.0000000000200771","article-title":"Genetic variation in targets of antidiabetic drugs and Alzheimer disease risk: a Mendelian randomization study","volume":"99","author":"Tang","year":"2022","journal-title":"Neurology"},{"issue":"9500","key":"10.1016\/j.jacl.2026.04.020_bib28","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"issue":"33","key":"10.1016\/j.jacl.2026.04.020_bib29","doi-asserted-by":"crossref","first-page":"25168","DOI":"10.1074\/jbc.M110.123992","article-title":"Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE3-Leiden","volume":"285","author":"Bijland","year":"2010","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.jacl.2026.04.020_bib30","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3390\/cells13171446","article-title":"PPAR-\u03b1 insufficiency enhances doxorubicin-induced nephropathy in PPAR-\u03b1 knockout mice and a murine podocyte cell line","volume":"13","author":"Matsuta","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jacl.2026.04.020_bib31","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1038\/s41467-019-11576-0","article-title":"Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria","volume":"10","author":"Teumer","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jacl.2026.04.020_bib32","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jacl.2026.04.020_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"issue":"21","key":"10.1016\/j.jacl.2026.04.020_bib34","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants","volume":"31","author":"Machiela","year":"2015","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.jacl.2026.04.020_bib35","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/metabo11110760","article-title":"Proteinuria-lowering effects of proprotein convertase subtilisin\/kexin type 9 inhibitors in chronic kidney disease patients: a real-world multicentric study","volume":"11","author":"Mu\u00f1oz Ramos","year":"2021","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.jacl.2026.04.020_bib36","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1016\/j.jacl.2024.07.004","article-title":"Genetic association analyses highlight apolipoprotein B as a determinant of chronic kidney disease in patients with type 2 diabetes","volume":"18","author":"Wang","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2026.04.020_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40259-022-00520-2","article-title":"A tale of two new targets for hypertriglyceridaemia: which choice of therapy?","volume":"36","author":"Ward","year":"2022","journal-title":"BioDrugs"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426001285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426001285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:24:25Z","timestamp":1783113865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426001285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1933287426001285"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.04.020","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The causal association between lipid-lowering drug targets and albuminuria risk: A drug-target Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}